People · Operator
Named in public records as an officer, director or promoter · active 2010–2017 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Merisant Co | — | Other | Series A | $12.5M | $189.2M | 2010 |
| Source Molecular Corp | — | Biotechnology | Seed | $1.6M | $71.8M | 2017 |
Jonathan Cole at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jonathan Cole on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eugene Davis | 1 | 6 |
| Ryan Langdon | 1 | 3 |
| Thierry Tamers | 1 | 1 |
| Mauricio Larenas | 1 | 1 |
| Paul Block | 1 | 1 |
| William Murnane | 1 | 1 |
| Carrie Murphy | 1 | 1 |
| Yann Kervoern | 1 | 1 |
| Joseph Deignan | 1 | 1 |
| Angelo Di Benedetto | 1 | 1 |
| Robert Waldron | 1 | 1 |
| Tom Paulson | 1 | 1 |
| Hugues Pitre | 1 | 1 |
| Brian Alsvig | 1 | 1 |
| Julie Wool | 1 | 1 |
| Kirk Shryoc, Jr. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.